NATASHA SHERRILL: Open Payments
NPI 1609380385 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 38 payments from 13 companies in 2025. Trend: 2023 $692 · 2024 $978 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $419 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Novo Nordisk Inc | 4 | $71 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: BOTOX, AIRSUPRA, UBRELVY, FARXIGA, VRAYLAR, Cologuard Collection Kit, MOUNJARO, Wegovy.
Industry payments across AK — which companies pay providers there.
